| CLASS | CHEM | LP7786-9 |
| COMPONENT | Daratumumab | LP420302-4 |
| PROPERTY | PrThr | LP217195-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser | LP7567-3 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Immunofixation | LP6336-4 |
| AnswerList | Detected|Not det | LL744-4 |
| parent | Lab terms not yet categorized | LP248770-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both |
| LONG_COMMON_NAME | en-US | Daratumumab [Presence] in Serum by Immunofixation |
| LONG_COMMON_NAME | en-US | Daratumumab [Presence] in Serum by Immunofixation |
| SHORTNAME | en-US | Daratumumab Ser Ql IFE |
| ConsumerName | en-US | Daratumumab, Blood |
| LONG_COMMON_NAME | fr-FR | Daratumumab [Présence/Seuil] Sérum ; Qualitatif ; Immunofixation |
| LONG_COMMON_NAME | nl-NL | Daratumumab [aanwezigheid] in serum d.m.v. immunofixatie |
| LinguisticVariantDisplayName | de-AT | Daratumumab Immunfixation |
| LONG_COMMON_NAME | es-MX | Daratumumab: Suero : Punto temporal: Presencia o umbral: Ordinal: Inmunofijación |
LOINC Version: 2.77
FHIR